Gossamer Bio Inc.(GOSS)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

GOSS Gossamer Bio Inc.

盘前交易 10-29 08:36:23 EDT

10.69

+0.92

+9.42%

最高10.88	最低9.45	成交量18.60万
今开9.61	昨收9.77	日振幅14.60%
总市值6,534万	流通市值4,092万	总股本611.25万
成交额191.76万	换手率4.86%	流通股本382.77万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"GOSS","market":"US","secType":"STK","nameCN":"Gossamer Bio Inc.","latestPrice":10.69,"timestamp":1793217600000,"preClose":9.77,"halted":0,"volume":186040,"delay":0,"changeRate":0.09416581371545547,"floatShares":3827700,"shares":6112499,"eps":-51.9692,"marketStatus":"盘前交易","change":0.92,"latestTime":"10-29 08:36:23 EDT","open":9.61,"high":10.8763,"low":9.45,"amount":1917609.90456,"amplitude":0.145988,"askPrice":10.71,"askSize":13,"bidPrice":9.15,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-51.9692,"tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1793280600000},"marketStatusCode":1,"adr":0,"adrRate":0,"listingDate":1549602000000,"exchange":"NASDAQ","adjPreClose":10.69,"postHourTrading":{"tag":"盘后","latestPrice":10.38,"preClose":10.69,"latestTime":"19:30 EDT","volume":414,"amount":4323.5238,"timestamp":1793230201230,"change":-0.31,"changeRate":-0.028999,"amplitude":0.028999},"volumeRatio":0.9860728602601496,"impliedVol":0.6236,"impliedVolPercentile":0.5324},"requestUrl":"/m/hq/s/GOSS","defaultTab":"news","newsList":[{"id":"1155387578","title":"Gossamer Bio Inc.获H.C. Wainwright调整目标价至90美元——1比80反向股票分割成关键因素","url":"https://stock-news.laohu8.com/highlight/detail?id=1155387578","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1155387578?lang=zh_cn&edition=full","pubTime":"2026-09-21 18:20","pubTimestamp":1789986043,"startTime":"0","endTime":"0","summary":"Gossamer Bio Inc.近期迎来重大市场动态。H.C. Wainwright分析师已将其目标股价调整至每股90美元，这一数字背后蕴含着对该公司实施1比80反向股票分割策略的直接响应。Gossamer Bio此番操作，无疑将对其股价的账面表现产生立竿见影的影响。H.C. Wainwright的最新目标价设定，正是在充分消化这一股本变动因素后所做出的前瞻性判断。市场参与者正密切关注，这一经过修正的价格锚点能否在后续交易中为Gossamer Bio的股价表现提供新的参照坐标。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4505","GOSS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1198506314","title":"Gossamer Bio董事会批准章程修订案，定于2026年9月3日正式生效","url":"https://stock-news.laohu8.com/highlight/detail?id=1198506314","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1198506314?lang=zh_cn&edition=full","pubTime":"2026-09-04 04:04","pubTimestamp":1788465851,"startTime":"0","endTime":"0","summary":"Gossamer Bio Inc.于今日通过美国证券交易委员会提交的文件披露，公司董事会已正式批准对公司章程进行修订与重述。这项决议在本次董事会会议上获得通过，并将于2026年9月3日起正式生效。Gossamer Bio方面表示，此次调整反映了公司持续完善治理框架的承诺，同时也为未来业务发展奠定了更为坚实的制度基础。作为一家处于临床阶段的生物制药企业，Gossamer Bio专注于创新疗法的研发，此次章程修订也被视为其规范化运作的又一重要步骤。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4505","GOSS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1116851334","title":"Gossamer Bio公布FDA监管进展，重获Seralutinib全球权利并发布业务更新","url":"https://stock-news.laohu8.com/highlight/detail?id=1116851334","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1116851334?lang=zh_cn&edition=full","pubTime":"2026-07-27 19:01","pubTimestamp":1785150115,"startTime":"0","endTime":"0","summary":"Gossamer Bio Inc.于今日正式对外宣布一项重要监管进展。该公司不仅获得了来自美国食品药品监督管理局的监管更新，还成功重获其核心药物Seralutinib的全球权益。与此同时，企业同步披露了最新的业务动态。\n这一系列举措彰显了Gossamer Bio在管线推进与战略整合上的积极姿态。Seralutinib作为一种潜在的治疗肺动脉高压的新药，其全球权利的重新获取意味着公司在未来研发与商业化布局中将拥有更大的自主权。\n在本次公告中，公司管理层强调，这些进展为后续的临床开发与市场拓展奠定了坚实基础。投资者正密切关注该公司下一步的具体行动方案。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4505","GOSS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1196490542","title":"Gossamer Bio Inc. 公布2030年到期7.50%可转换优先有担保第一留置权票据转换率及购股权证行权价","url":"https://stock-news.laohu8.com/highlight/detail?id=1196490542","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1196490542?lang=zh_cn&edition=full","pubTime":"2026-07-01 21:01","pubTimestamp":1782910874,"startTime":"0","endTime":"0","summary":"Gossamer Bio Inc. 已正式确定其2030年到期的7.50%可转换优先有担保第一留置权票据的转换比率，并同时公布了相关购股权证的行权价格。此举标志着公司融资工具关键条款的最终敲定，为投资者提供了明确的转换与行权依据。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","GOSS","BK4505"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1174119316","title":"Gossamer Bio Inc. 公布现有可转换票据交换要约及同意征求最终投标结果","url":"https://stock-news.laohu8.com/highlight/detail?id=1174119316","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1174119316?lang=zh_cn&edition=full","pubTime":"2026-06-17 20:00","pubTimestamp":1781697646,"startTime":"0","endTime":"0","summary":"Gossamer Bio Inc. 已正式公布其针对现有可转换票据的交换要约及同意征求的最终投标结果。公司确认，相关程序已按计划完成，并取得了预期的参与度。此举是公司优化资本结构、管理债务到期情况的重要步骤。最终结果的公布为市场提供了明确信息，标志着这一财务操作的关键阶段已告结束。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4505","GOSS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1148661807","title":"Gossamer Bio Inc. 宣布延长现有可转换票据交换要约及同意征求的早期投标截止日","url":"https://stock-news.laohu8.com/highlight/detail?id=1148661807","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1148661807?lang=zh_cn&edition=full","pubTime":"2026-06-02 20:01","pubTimestamp":1780401689,"startTime":"0","endTime":"0","summary":"Gossamer Bio Inc. 宣布，针对其现有可转换票据的交换要约及同意征求，公司已决定将早期投标的截止日期予以延长。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","GOSS","BK4505"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1102631624","title":"Gossamer Bio Inc. 启动交换要约与征求同意，旨在依托现有票据持有人支持消除超1.2亿美元债务","url":"https://stock-news.laohu8.com/highlight/detail?id=1102631624","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1102631624?lang=zh_cn&edition=full","pubTime":"2026-05-18 19:06","pubTimestamp":1779102381,"startTime":"0","endTime":"0","summary":"Gossamer Bio Inc. 宣布启动一项交换要约及同步的同意征求。此举旨在获得现有票据持有人的支持，以消除公司账面上超过1.2亿美元的债务。该策略意在优化资本结构，减轻财务负担。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","GOSS","BK4505"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2518027458","title":"Gossamer Bio, Inc.盘中异动 早盘急速下跌5.37%报1.15美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2518027458","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2518027458?lang=zh_cn&edition=full","pubTime":"2025-03-10 23:24","pubTimestamp":1741620245,"startTime":"0","endTime":"0","summary":"北京时间2025年03月10日23时24分，Gossamer Bio, Inc.股票出现波动，股价快速下跌5.37%。截至发稿，该股报1.15美元/股，成交量34.5502万股，换手率0.15%，振幅6.20%。Gossamer Bio, Inc.股票所在的生物技术行业中，整体涨幅为0.86%。其相关个股中，Aeon Biopharma, Inc.、Checkpoint Therapeutics, Inc.、Mineralys Therapeutics, Inc.涨幅较大，Biodexa Pharmaceuticals Plc、Aeon Biopharma, Inc.、Scisparc Ltd.较为活跃，换手率分别为3606.98%、1130.61%、802.76%，振幅较大的相关个股有Aeon Biopharma, Inc.、Scisparc Ltd.、Dogwood Therapeutics, Inc.，振幅分别为51.05%、49.87%、41.36%。Gossamer Bio, Inc.公司简介：Gossamer Bio Inc是一家处于临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025031023240596404fff&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025031023240596404fff&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4505","GOSS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2516677355","title":"Gossamer Bio, Inc.盘中异动 股价大跌5.08%报1.12美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2516677355","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2516677355?lang=zh_cn&edition=full","pubTime":"2025-03-04 22:32","pubTimestamp":1741098771,"startTime":"0","endTime":"0","summary":"北京时间2025年03月04日22时32分，Gossamer Bio, Inc.股票出现异动，股价急速下跌5.08%。Gossamer Bio, Inc.股票所在的生物技术行业中，整体涨幅为0.25%。其相关个股中，Cero Therapeutics Holdings Inc C/Wts 13/02/2029 、Protagenic Therapeutics, Inc.、Exicure, Inc.涨幅较大，Aeon Biopharma, Inc.、Windtree Therapeutics, Inc.、Protagenic Therapeutics, Inc.较为活跃，换手率分别为1054.48%、1052.09%、415.30%，振幅较大的相关个股有Celularity Inc C/Wts 16/07/2026 、Adma Biologics Inc、Amylyx Pharmaceuticals, Inc.，振幅分别为23.30%、12.57%、11.00%。Gossamer Bio, Inc.公司简介：Gossamer Bio Inc是一家处于临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304223251a25f0502&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304223251a25f0502&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4505","GOSS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514373339","title":"Gossamer Bio, Inc.盘中异动 早盘股价大跌5.04%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514373339","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2514373339?lang=zh_cn&edition=full","pubTime":"2025-02-28 22:32","pubTimestamp":1740753144,"startTime":"0","endTime":"0","summary":"北京时间2025年02月28日22时32分，Gossamer Bio, Inc.股票出现异动，股价快速下挫5.04%。Gossamer Bio, Inc.股票所在的生物技术行业中，整体涨幅为0.05%。其相关个股中，Enveric Biosciences, Inc.、Virpax Pharmaceuticals, Inc.、Tc Biopharm  Plc C/Wts 10/02/2028 涨幅较大，Bioxcel Therapeutics, Inc.、Virpax Pharmaceuticals, Inc.、Enveric Biosciences, Inc.较为活跃，换手率分别为483.74%、242.14%、62.32%，振幅较大的相关个股有Cardio Diagnostics Holdings Inc C/Wts  To Pur Com、Enveric Biosciences, Inc.、Abcellera Biologics Inc.，振幅分别为31.14%、9.91%、8.73%。Gossamer Bio, Inc.公司简介：Gossamer Bio Inc是一家处于临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228223224a2580166&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228223224a2580166&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["GOSS","BK4139","BK4505"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514867417","title":"Gossamer Bio, Inc.盘中异动 股价大涨5.16%报1.33美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514867417","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2514867417?lang=zh_cn&edition=full","pubTime":"2025-02-27 04:52","pubTimestamp":1740603120,"startTime":"0","endTime":"0","summary":"北京时间2025年02月27日04时52分，Gossamer Bio, Inc.股票出现波动，股价急速拉升5.16%。截至发稿，该股报1.33美元/股，成交量147.224万股，换手率0.65%，振幅7.08%。Gossamer Bio, Inc.股票所在的生物技术行业中，整体跌幅为0.55%。其相关个股中，Enveric Biosciences, Inc.、Renovaro Inc.、Apollomics Inc C/Wts 01/04/2028 涨幅较大，Enveric Biosciences, Inc.、Aeon Biopharma, Inc.、Organovo Holdings, Inc.较为活跃，换手率分别为6933.13%、367.50%、268.58%，振幅较大的相关个股有Enveric Biosciences, Inc.、Renovaro Inc.、Immatics N V C/Wts 01/07/2025 ，振幅分别为194.07%、81.11%、70.39%。Gossamer Bio, Inc.公司简介：Gossamer Bio Inc是一家处于临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250227045200a2554a83&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250227045200a2554a83&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4505","GOSS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514015884","title":"Gossamer Bio, Inc.盘中异动 早盘股价大跌5.13%报1.23美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514015884","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2514015884?lang=zh_cn&edition=full","pubTime":"2025-02-25 23:11","pubTimestamp":1740496281,"startTime":"0","endTime":"0","summary":"北京时间2025年02月25日23时11分，Gossamer Bio, Inc.股票出现异动，股价快速下跌5.13%。Gossamer Bio, Inc.股票所在的生物技术行业中，整体涨幅为0.81%。其相关个股中，Silexion Therapeutics Corp、Abpro Holdings Inc C/Wts 12/11/2029 、Lava Therapeutics N.V.涨幅较大，Gt Biopharma, Inc.、Moleculin Biotech, Inc.、Adial Pharmaceuticals, Inc较为活跃，换手率分别为1039.44%、582.78%、531.65%，振幅较大的相关个股有Adial Pharmaceuticals, Inc、Gri Bio, Inc.、Cero Therapeutics Holdings Inc C/Wts 13/02/2029 ，振幅分别为58.82%、56.51%、43.70%。Gossamer Bio, Inc.公司简介：Gossamer Bio Inc是一家处于临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225231122989255e3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225231122989255e3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4505","GOSS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2513717722","title":"Gossamer Bio, Inc.盘中异动 急速下挫5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2513717722","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2513717722?lang=zh_cn&edition=full","pubTime":"2025-02-24 22:32","pubTimestamp":1740407549,"startTime":"0","endTime":"0","summary":"北京时间2025年02月24日22时32分，Gossamer Bio, Inc.股票出现波动，股价急速跳水5.00%。Gossamer Bio, Inc.股票所在的生物技术行业中，整体跌幅为0.09%。其相关个股中，Aspire Biopharma Holdings Inc C/Wts 14/02/2030 、Psyence Biomedical Ltd C/Wts 25/01/2029、Nutriband Inc C/Wts 涨幅较大，Aditxt, Inc.、Biodexa Pharmaceuticals Plc、Acurx Pharmaceuticals, Inc.较为活跃，换手率分别为40.29%、24.06%、17.71%，振幅较大的相关个股有Gossamer Bio, Inc.、Summit Therapeutics Inc.、Estrella Immunopharma, Inc.，振幅分别为14.69%、12.61%、12.38%。Gossamer Bio, Inc.公司简介：Gossamer Bio Inc是一家处于临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502242232299890f5bc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502242232299890f5bc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["GOSS","BK4505","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2513152294","title":"Gossamer Bio, Inc.盘中异动 大幅下挫5.23%报1.45美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2513152294","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2513152294?lang=zh_cn&edition=full","pubTime":"2025-02-21 23:39","pubTimestamp":1740152363,"startTime":"0","endTime":"0","summary":"北京时间2025年02月21日23时39分，Gossamer Bio, Inc.股票出现波动，股价急速下挫5.23%。Gossamer Bio, Inc.股票所在的生物技术行业中，整体跌幅为0.07%。其相关个股中，Osr Holdings Inc C/Wts 09/02/2028 、Nkgen Biotech Inc C/Wts 31/05/2028、Nkgen Biotech, Inc.涨幅较大，Nkgen Biotech, Inc.、Aditxt, Inc.、蓝鸟生物较为活跃，换手率分别为177.95%、113.34%、35.32%，振幅较大的相关个股有Osr Holdings Inc C/Wts 09/02/2028 、Nkgen Biotech, Inc.、Lexaria Bioscience Corp C/Wts 14/01/2026 ，振幅分别为57.50%、48.19%、36.69%。Gossamer Bio, Inc.公司简介：Gossamer Bio Inc是一家处于临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250221233923988dedd8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250221233923988dedd8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","GOSS","BK4505"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2512165692","title":"Gossamer Bio, Inc.盘中异动 早盘急速上涨6.11%报1.39美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2512165692","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2512165692?lang=zh_cn&edition=full","pubTime":"2025-02-18 22:43","pubTimestamp":1739889784,"startTime":"0","endTime":"0","summary":"北京时间2025年02月18日22时43分，Gossamer Bio, Inc.股票出现异动，股价大幅拉升6.11%。Gossamer Bio, Inc.股票所在的生物技术行业中，整体涨幅为0.60%。其相关个股中，Solid Biosciences Inc.、Revolution Medicines Inc C/Wts 17/12/2026 、Psyence Biomedical Ltd C/Wts 25/01/2029涨幅较大，Aditxt, Inc.、Solid Biosciences Inc.、Moleculin Biotech, Inc.较为活跃，换手率分别为303.45%、108.43%、87.13%，振幅较大的相关个股有Jasper Therapeutics Inc C/Wts 24/09/2026 、Conduit Pharmaceuticals Inc.、Pulmatrix, Inc.，振幅分别为34.04%、26.83%、23.16%。Gossamer Bio, Inc.公司简介：Gossamer Bio Inc是一家处于临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502182243059889ff4f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502182243059889ff4f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","GOSS","BK4505"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2511269736","title":"Gossamer Bio, Inc.盘中异动 股价大跌5.34%报1.24美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2511269736","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2511269736?lang=zh_cn&edition=full","pubTime":"2025-02-15 00:17","pubTimestamp":1739549848,"startTime":"0","endTime":"0","summary":"北京时间2025年02月15日00时17分，Gossamer Bio, Inc.股票出现异动，股价大幅跳水5.34%。Gossamer Bio, Inc.股票所在的生物技术行业中，整体跌幅为0.60%。其相关个股中，Moleculin Biotech, Inc.、Nls Pharmaceutics Ltd C/Wts 02/02/2026、Allogene Therapeutics, Inc.涨幅较大，Moleculin Biotech, Inc.、Cns Pharmaceuticals, Inc.、Virpax Pharmaceuticals, Inc.较为活跃，换手率分别为2690.05%、704.46%、534.86%，振幅较大的相关个股有Moleculin Biotech, Inc.、Abpro Holdings Inc C/Wts 12/11/2029 、Psyence Biomedical Ltd C/Wts 25/01/2029，振幅分别为66.93%、58.14%、54.40%。Gossamer Bio, Inc.公司简介：Gossamer Bio Inc是一家处于临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502150017299885a262&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502150017299885a262&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4505","GOSS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2511052521","title":"Gossamer Bio, Inc.盘中异动 早盘股价大涨5.12%报1.34美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2511052521","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2511052521?lang=zh_cn&edition=full","pubTime":"2025-02-13 22:31","pubTimestamp":1739457099,"startTime":"0","endTime":"0","summary":"北京时间2025年02月13日22时31分，Gossamer Bio, Inc.股票出现波动，股价大幅上涨5.12%。截至发稿，该股报1.34美元/股，成交量6.1637万股，换手率0.03%，振幅1.73%。Gossamer Bio, Inc.股票所在的生物技术行业中，整体跌幅为0.01%。其相关个股中，Moleculin Biotech, Inc.、Edesa Biotech, Inc.、Tc Biopharm  Plc C/Wts 10/02/2028 涨幅较大，Tc Biopharm  Plc、Edesa Biotech, Inc.、Genprex, Inc.较为活跃，换手率分别为977.79%、792.05%、90.75%，振幅较大的相关个股有Moleculin Biotech, Inc.、Edesa Biotech, Inc.、Omega Therapeutics, Inc.，振幅分别为30.00%、25.80%、9.38%。Gossamer Bio, Inc.公司简介：Gossamer Bio Inc是一家处于临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502132231409621bbd1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502132231409621bbd1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["GOSS","BK4505","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2510808283","title":"Gossamer Bio, Inc.盘中异动 早盘快速下跌5.13%","url":"https://stock-news.laohu8.com/highlight/detail?id=2510808283","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2510808283?lang=zh_cn&edition=full","pubTime":"2025-02-11 22:38","pubTimestamp":1739284725,"startTime":"0","endTime":"0","summary":"北京时间2025年02月11日22时38分，Gossamer Bio, Inc.股票出现波动，股价急速下挫5.13%。截至发稿，该股报1.11美元/股，成交量5.8933万股，换手率0.03%，振幅5.13%。Gossamer Bio, Inc.股票所在的生物技术行业中，整体跌幅为0.92%。其相关个股中，Dominari Holdings Inc.、Ocean Biomedical, Inc.、Lipella Pharmaceuticals Inc.涨幅较大，Lipella Pharmaceuticals Inc.、Ocean Biomedical, Inc.、Dominari Holdings Inc.较为活跃，换手率分别为2204.98%、564.93%、215.82%，振幅较大的相关个股有In8Bio, Inc.、Ocean Biomedical, Inc.、Dominari Holdings Inc.，振幅分别为31.80%、29.73%、25.49%。Gossamer Bio, Inc.公司简介：Gossamer Bio Inc是一家处于临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250211223845961f4921&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250211223845961f4921&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","GOSS","OCEA","BK4505"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2510861630","title":"Gossamer Bio, Inc.盘中异动 急速拉升5.19%","url":"https://stock-news.laohu8.com/highlight/detail?id=2510861630","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2510861630?lang=zh_cn&edition=full","pubTime":"2025-02-10 23:22","pubTimestamp":1739200940,"startTime":"0","endTime":"0","summary":"北京时间2025年02月10日23时22分，Gossamer Bio, Inc.股票出现异动，股价急速上涨5.19%。Gossamer Bio, Inc.股票所在的生物技术行业中，整体跌幅为0.18%。其相关个股中，Biodexa Pharmaceuticals Plc、60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 、Neurosense Therapeutics Ltd C/Wts 10/11/2026 涨幅较大，Biodexa Pharmaceuticals Plc、Nls Pharmaceutics Ltd.、Ocean Biomedical, Inc.较为活跃，换手率分别为2505.17%、1488.80%、944.33%，振幅较大的相关个股有Ocean Biomedical, Inc.、Biodexa Pharmaceuticals Plc、Immatics N V C/Wts 01/07/2025 ，振幅分别为69.83%、66.09%、50.50%。Gossamer Bio, Inc.公司简介：Gossamer Bio Inc是一家处于临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025021023222098808329&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025021023222098808329&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","GOSS","BK4505"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2509574069","title":"Gossamer Bio, Inc.盘中异动 股价大跌5.41%报1.05美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2509574069","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2509574069?lang=zh_cn&edition=full","pubTime":"2025-02-07 22:58","pubTimestamp":1738940280,"startTime":"0","endTime":"0","summary":"北京时间2025年02月07日22时58分，Gossamer Bio, Inc.股票出现波动，股价大幅下跌5.41%。截至发稿，该股报1.05美元/股，成交量6.1858万股，换手率0.03%，振幅2.25%。Gossamer Bio, Inc.股票所在的生物技术行业中，整体涨幅为0.22%。Gossamer Bio, Inc.公司简介：Gossamer Bio Inc是一家处于临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250207225800961b3dac&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250207225800961b3dac&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4505","BK4139","GOSS"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.gossamerbio.com;ir.gossamerbio.com","stockEarnings":[{"period":"1week","weight":0.0919},{"period":"1month","weight":-0.072},{"period":"3month","weight":-0.2506},{"period":"6month","weight":-0.6387},{"period":"1year","weight":-0.9439},{"period":"ytd","weight":-0.9569}],"compareEarnings":[{"period":"1week","weight":-0.001},{"period":"1month","weight":0.0088},{"period":"3month","weight":0.0413},{"period":"6month","weight":0.0717},{"period":"1year","weight":0.1241},{"period":"ytd","weight":0.1326}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Gossamer Bio, Inc.于2015年10月26日根据特拉华州法律注册成立。该公司是一家临床阶段的生物制药公司，专注于开发和商业化seralutinib，用于治疗肺动脉高压，包括肺动脉高压和与间质性肺病相关的肺动脉高压。它由一支在领先生物制药公司拥有丰富经验的管理团队领导。","yearOnYearQuotes":[{"month":1,"riseRate":0.428571,"avgChangeRate":-0.040994},{"month":2,"riseRate":0.285714,"avgChangeRate":-0.054405},{"month":3,"riseRate":0,"avgChangeRate":-0.132047},{"month":4,"riseRate":0.375,"avgChangeRate":-0.066505},{"month":5,"riseRate":0.5,"avgChangeRate":-0.050109},{"month":6,"riseRate":0.625,"avgChangeRate":0.083834},{"month":7,"riseRate":0.625,"avgChangeRate":0.11719},{"month":8,"riseRate":0.75,"avgChangeRate":0.085592},{"month":9,"riseRate":0.375,"avgChangeRate":-0.040274},{"month":10,"riseRate":0.125,"avgChangeRate":-0.108373},{"month":11,"riseRate":0.571429,"avgChangeRate":0.095879},{"month":12,"riseRate":0.571429,"avgChangeRate":-0.08654}],"exchange":"NASDAQ","name":"Gossamer Bio Inc.","nameEN":"Gossamer Bio Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.52.0","shortVersion":"4.52.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Gossamer Bio Inc.(GOSS)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Gossamer Bio Inc.(GOSS)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Gossamer Bio Inc.,GOSS,Gossamer Bio Inc.股票,Gossamer Bio Inc.股票老虎,Gossamer Bio Inc.股票老虎国际,Gossamer Bio Inc.行情,Gossamer Bio Inc.股票行情,Gossamer Bio Inc.股价,Gossamer Bio Inc.股市,Gossamer Bio Inc.股票价格,Gossamer Bio Inc.股票交易,Gossamer Bio Inc.股票购买,Gossamer Bio Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Gossamer Bio Inc.(GOSS)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Gossamer Bio Inc.(GOSS)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}